These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

75 related items for PubMed ID: 21809691

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Switching from benzodiazepines to buspirone using a tapered overlap method in generalized anxiety disorder.
    Arató M.
    J Clin Psychiatry; 2001 Aug; 62(8):657-8. PubMed ID: 11561943
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Optimization of the treatment of anxiety disorders with selank].
    Medvedev VE, Tereshchenko ON, Kost NV, Ter-Israelyan AY, Gushanskaya EV, Chobanu IK, Sokolov OY, Myasoedov NF.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015 Aug; 115(6):33-40. PubMed ID: 26356395
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effects of treatment with etizolam 0.5 mg BID on cognitive performance: a 3-week, multicenter, randomized, double-blind, placebo-controlled, two-treatment, three-period, noninferiority crossover study in patients with anxiety disorder.
    De Candia MP, Di Sciascio G, Durbano F, Mencacci C, Rubiera M, Aguglia E, Garavini A, Bersani G, Di Sotto A, Placidi G, Cesana BM.
    Clin Ther; 2009 Dec; 31(12):2851-9. PubMed ID: 20110024
    [Abstract] [Full Text] [Related]

  • 10. [A comparison of the anxiolytic effect and tolerability of selank and phenazepam in the treatment of anxiety disorders].
    Medvedev VE, Tereshchenko ON, Israelian AIu, Chobanu IK, Kost NV, Sokolov OIu, Miasoedov NF.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2014 Dec; 114(7):17-22. PubMed ID: 25176261
    [Abstract] [Full Text] [Related]

  • 11. Effects of CYP2C19*17 polymorphisms on the efficacy and safety of bromodigyrochlorophenylbenzodiazepine in patients with anxiety disorder and comorbid alcohol use disorder.
    Zastrozhin MS, Antonenko AP, Nesterenko EV, Seyfullaeva LI, Mustafina VR, Esakova AP, Grishina EA, Sorokin AS, Skryabin VY, Savchenko LM, Bryun EA, Sychev DA.
    Drug Metab Pers Ther; 2018 Dec 19; 33(4):187-194. PubMed ID: 30325732
    [Abstract] [Full Text] [Related]

  • 12. [Clinical, psychological and electromyographic observations on treatment with Seduxen].
    Predescu V, Florescu D, Ciurezu T, Zelingher R, Ivana D.
    Neurol Psihiatr Neurochir; 1971 Dec 19; 16(5):409-13. PubMed ID: 4256805
    [No Abstract] [Full Text] [Related]

  • 13. Alpidem and lorazepam in the treatment of patients with anxiety disorders: comparison of physiological and psychological effects.
    Morton S, Lader M.
    Pharmacopsychiatry; 1992 Jul 19; 25(4):177-81. PubMed ID: 1356277
    [Abstract] [Full Text] [Related]

  • 14. [Effect of afobazole on the psychophysiological state of healthy volunteers].
    Bogdan NG, Kolotilinskaia NV, Nadorov SA, Iarkova MA, Badyshtov BA.
    Eksp Klin Farmakol; 2011 Jul 19; 74(8):8-12. PubMed ID: 22232907
    [Abstract] [Full Text] [Related]

  • 15. Effects of transdermal nicotine on prose memory and attention in smokers and nonsmokers.
    Poltavski DV, Petros T.
    Physiol Behav; 2005 Jan 17; 83(5):833-43. PubMed ID: 15639169
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Low-sedation potential of buspirone compared with alprazolam and lorazepam in the treatment of anxious patients: a double-blind study.
    Cohn JB, Wilcox CS.
    J Clin Psychiatry; 1986 Aug 17; 47(8):409-12. PubMed ID: 2874128
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. CYP3A subfamily activity affects the equilibrium concentration of Phenazepam® in patients with anxiety disorders and comorbid alcohol use disorder.
    Zastrozhin MS, Skryabin VY, Sorokin AS, Petukhov AE, Smirnov VV, Pankratenko EP, Grishina EA, Ryzhikova KA, Panov AS, Savchenko LM, Bryun EA, Sychev DA.
    Pharmacogenomics; 2020 May 17; 21(7):449-457. PubMed ID: 32336193
    [Abstract] [Full Text] [Related]

  • 20. Effects of anxiety on attentional allocation and task performance: an information processing analysis.
    Dibartolo PM, Brown TA, Barlow DH.
    Behav Res Ther; 1997 Dec 17; 35(12):1101-11. PubMed ID: 9465443
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.